ClinicalTrials.Veeva

Menu

Cognitive Impairment and Cerebral Haemodynamics in Individuals With Symptomatic Peripheral Arterial Disease (CInCH PAD)

U

University of Leicester

Status

Not yet enrolling

Conditions

Cognitive Impairment
Peripheral Arterial Disease

Treatments

Diagnostic Test: Ankle-brachial pressure index
Diagnostic Test: Cerebral haemodynamic testing using transcranial Doppler
Diagnostic Test: Six-minute walk test

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Background:

Arterial disease of the legs causes symptoms such as pain when walking and may ultimately lead to a leg amputation. Many older people with arterial disease of the legs also have problems with their thinking and memory. Blood flow in the brain may be altered in these people and may be a cause for memory and thinking problems.

Aim:

The aim of this project is to investigate whether people with arterial disease of the legs have altered blood flow in the brain causing problems with memory and thinking.

Research plan:

Twenty people with arterial disease of the legs causing pain while walking and twenty healthy people will have a series of non-invasive assessments. Arterial disease in the legs will be measured using ankle blood pressures before and after walking. Blood flow in the brain will be measured using ultrasound whilst performing memory and thinking tests. Results will be compared between the people with arterial disease in the legs and the healthy people to see if there are any differences in blood flow to the brain and memory and thinking.

Benefits to society:

This project will help determine if there is a link between arterial disease of the legs and memory and thinking problems caused by altered blood flow in the brain. It will enable future research in people with cognitive impairment caused by altered blood supply to the brain and to prevent confusion and further memory and thinking problems in people undergoing surgery for arterial disease of the legs.

Enrollment

40 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Capacity to provide Informed volunteer/patient consent
  • Male or female, aged ≥50 years of age
  • Able (in the Investigator's opinion) and willing to comply with all study requirements
  • Good understanding of written and verbal English

Peripheral arterial disease specific inclusion criteria:

  • Clinical diagnosis of symptomatic PAD (intermittent claudication) confirmed by positive haemodynamic tests (ABPI <0.90 in the symptomatic leg; and/or,
  • Post-exercise [walk test] reduction in ABPI of >20% or post-exercise [walk test] reduction in absolute ankle pressure of >30mmHg)

Exclusion criteria

  • Male or Female, aged under 50 years
  • Pregnant
  • Unable (in the Investigator's opinion) or unwilling to comply with any study requirements
  • Major co-morbidity likely to affect cerebral autoregulation; severe respiratory disease, unilateral carotid artery stenosis (≥50%), atrial fibrillation, severe cardiac failure (left ventricular ejection fraction <20%), or extreme frailty
  • History of significant diagnosed psychiatric disorder, learning disability (e.g. dyslexia) or neurological disorder (head injury, epilepsy, stroke and/or transient ischaemic attack [TIA])
  • Diagnosis of dementia
  • Uncorrected hearing impairment and/or significant visual impairment

Healthy control specific exclusion criteria

  • Symptoms of intermittent claudication; and/or,
  • Clinical diagnosis or history of PAD

Trial design

40 participants in 2 patient groups

Individuals with symptomatic peripheral arterial disease
Description:
Individuals with intermittent claudication caused by confirmed peripheral arterial disease defined as a resting ankle-brachial pressure index of \<0.9 and/or a post-exercise reduction in either ankle-brachial pressure index of \>20% or absolute ankle pressure of \>30mmHg.
Treatment:
Diagnostic Test: Cerebral haemodynamic testing using transcranial Doppler
Diagnostic Test: Six-minute walk test
Diagnostic Test: Ankle-brachial pressure index
Healthy controls
Description:
Age- and sex-matched cohort of individuals without peripheral arterial disease.
Treatment:
Diagnostic Test: Cerebral haemodynamic testing using transcranial Doppler
Diagnostic Test: Six-minute walk test
Diagnostic Test: Ankle-brachial pressure index

Trial contacts and locations

1

Loading...

Central trial contact

Tanya J Payne; John SM Houghton

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems